Press Releases

 
Press Releases
  Date Title View
Jun 13, 2017
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the upsizing and pricing of its previously announced underwritten public offering of 6,382,978 shares of its common stock at a pub...
PDF
Jun 12, 2017
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that it has commenced an underwritten public offering of $65,000,000 of shares of its common stock. All of the shares in the offer...
PDF
Jun 12, 2017
The True Sample-to-Answer Solution™ Brings New Capabilities to Multiplex Molecular Diagnostics CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it ...
PDF
May 31, 2017
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, will present at the 2017 William Blair Growth Stock Conference in Chicago on Tuesday, June 13, 2017. The presentation will be delivered by Hany Ma...
PDF
May 3, 2017
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, will present at the Bank of America Merrill Lynch 2017 Health Care Conference in Las Vegas, Nevada, on Tuesday, May 16, 2017. The presentation will be ...
PDF
May 2, 2017
First Quarter Revenue Increased 13% Versus Prior Year to $12.5 million Over 70 ePlex® Customer Agreements in Place Totaling More than 100 Analyzers ePlex Blood Culture Identification Fungal Pathogen Panel CE Mark Achieved CARLSBAD...
PDF
Apr 20, 2017
PDF
Apr 18, 2017
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its first quarter earnings results after market close on Tuesday, May 2, 2017. Management will hold a conference call to review the Company's financial performance starting at 4:30 p.m. ET on the s...
PDF
Mar 28, 2017
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, will present at the 16th Annual Needham Healthcare Conference to be held at the Westin Grand Central in New York on Wednesday, April 5, 2017. The ...
PDF
Mar 2, 2017
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, will present at Cowen and Company's 37th Annual Health Care Conference to be held at the Marriott Copley Place in Boston, Massachusetts on Wednesd...
PDF
1
...
NextLast